Your browser doesn't support javascript.
loading
Implementation of an antimicrobial stewardship programme in three regional hospitals in the south-east of Liberia: lessons learned.
Alabi, Abraham S; Picka, Stephen W; Sirleaf, Reubvera; Ntirenganya, Pacifique R; Ayebare, Arnold; Correa, Nidia; Anyango, Sarah; Ekwen, Gerald; Agu, Emmanuel; Cook, Rebecca; Yarngrorble, John; Sanoe, Ibrahim; Dugulu, Henry; Wiefue, Emmanuel; Gahn-Smith, Diana; Kateh, Francis N; Hallie, Ezekiel F; Sidonie, Christiane G; Aboderin, Aaron O; Vassellee, David; Bishop, Damien; Lohmann, Daniel; Naumann-Hustedt, Manja; Dörlemann, Alois; Schaumburg, Frieder.
Afiliação
  • Alabi AS; Health Focus GmbH, Friedrich-Ebert-Straße 33, 14469 Potsdam, Germany.
  • Picka SW; Health Focus GmbH, Friedrich-Ebert-Straße 33, 14469 Potsdam, Germany.
  • Sirleaf R; Health Focus GmbH, Friedrich-Ebert-Straße 33, 14469 Potsdam, Germany.
  • Ntirenganya PR; Partners In Health, Sophie Road Oldest, Congo Town, Monrovia, Liberia.
  • Ayebare A; Partners In Health, Sophie Road Oldest, Congo Town, Monrovia, Liberia.
  • Correa N; Partners In Health, Boston, MA, USA.
  • Anyango S; Partners In Health, Sophie Road Oldest, Congo Town, Monrovia, Liberia.
  • Ekwen G; Partners In Health, Sophie Road Oldest, Congo Town, Monrovia, Liberia.
  • Agu E; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Cook R; Partners In Health, Sophie Road Oldest, Congo Town, Monrovia, Liberia.
  • Yarngrorble J; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Sanoe I; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Dugulu H; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Wiefue E; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Gahn-Smith D; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Kateh FN; Ministry of Health, Capitol Bye-Pass, Monrovia, Liberia.
  • Hallie EF; School of Pharmacy, University of Liberia, Monrovia, Liberia.
  • Sidonie CG; Centre de Recherches Medicales, CERMEL, Lambarene, Gabon.
  • Aboderin AO; Obafemi Awolowo University, Ile-Ife, Nigeria.
  • Vassellee D; German Corporation for International Cooperation, GIZ, Tubman Boulevard, Congo Town, Monrovia, Liberia.
  • Bishop D; German Corporation for International Cooperation, GIZ, Tubman Boulevard, Congo Town, Monrovia, Liberia.
  • Lohmann D; German Corporation for International Cooperation, GIZ, Tubman Boulevard, Congo Town, Monrovia, Liberia.
  • Naumann-Hustedt M; Health Focus GmbH, Friedrich-Ebert-Straße 33, 14469 Potsdam, Germany.
  • Dörlemann A; Health Focus GmbH, Friedrich-Ebert-Straße 33, 14469 Potsdam, Germany.
  • Schaumburg F; Institute of Medical Microbiology, University of Münster, Münster, Germany.
JAC Antimicrob Resist ; 4(3): dlac069, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35769809
ABSTRACT

Background:

Antimicrobial stewardship (AMS) programmes can improve the use of antimicrobial agents. However, there is limited experience in the implementation of such programmes in low- and middle-income countries (LMICs).

Objectives:

To assess the effect of AMS measures in south-east Liberia on the quality of antimicrobial use in three regional hospitals.

Methods:

A bundle of three measures (local treatment guideline, training and regular AMS ward rounds) was implemented and quality indicators of antimicrobial use (i.e. correct compounds, dosage and duration) were assessed in a case series before and after AMS ward rounds. Primary endpoints were (i) adherence to the local treatment guideline; (ii) completeness of the microbiological diagnostics (according to the treatment guideline); and (iii) clinical outcome. The secondary endpoint was reduction in ceftriaxone use.

Results:

The majority of patients had skin and soft tissue infections (n = 108) followed by surgical site infections (n = 72), pneumonia (n = 64), urinary tract infection (n = 48) and meningitis (n = 18). After the AMS ward rounds, adherence to the local guideline improved for the selection of antimicrobial agents (from 34.5% to 61.0%, P < 0.0005), dosage (from 15.2% to 36.5%, P < 0.0005) and duration (from 13.2% to 31.0%, P < 0.0005). In total, 79.7% of patients (247/310) had samples sent for microbiological analysis. Overall, 92.3% of patients improved on Day 3 (286/310). The proportion of patients receiving ceftriaxone was significantly reduced after the AMS ward rounds from 51.3% to 14.2% (P < 0.0005).

Conclusions:

AMS measures can improve the quality of antimicrobial use in LMICs. However, long-term engagement is necessary to make AMS programmes in LMICs sustainable.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Sysrev_observational_studies Idioma: En Revista: JAC Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Sysrev_observational_studies Idioma: En Revista: JAC Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha